Primary Outcomes of the Esprit™ BTK Drug-Eluting Resorbable Scaffold for the Treatment of Infrapopliteal Lesions: The LIFE-BTK Randomized Controlled Trial
Original Broadcast: October 25, 2023
Conference: TCT 2023
Late-Breaking Trial Presenter: Ramon L. Varcoe
This website uses cookies to ensure you get the best experience on our website. Read More
